Premal Thaker

2025

Diverse case series of granulomatous peritonitis mimicking advanced ovarian cancer

Furuya, R. L., Rimel, B. J., Tsai, R., Brooks, R. A., Stewart Massad, L., Thaker, P. H. & Pfeifer, J. D., Apr 2025, In: Gynecologic Oncology Reports. 58, 101712.

Research output: Contribution to journal › Article › peer-review

Open Access

Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis

Alvero, A. B., Wu, S., Farrell, A., Kim, S., Wallbillich, J. J., Winer, I., Morris, R., Spetzler, D., Anderson, M. L., Puccini, A., Jones, N. L., Herzog, T. J., Thaker, P. H., Mor, G. & Gogoi, R. P., Mar 2025, In: Gynecologic oncology. 194, p. 71-79 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study

Secord, A. A., Bae-Jump, V., Backes, F., Thaker, P., Gehrig, P. A., Previs, R. A., Borden, L., Thomas, S. M., Jackson, A., Konecny, G. E., Duska, L. R., Arend, R., Wright, J., Corr, B., Maxwell, G. L., Cosgrove, C. M., Mullen, M. M., Washington, C., Herzog, T. J. & Cohen, J. & 5 others, Hou, J., Gaillard, S., Fader, A. N., Berchuck, A. & Pothuri, B., May 2025, In: International Journal of Gynecological Cancer. 35, 5, 101758.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial

You, B., Anderson, C., Cecere, S. C., Carrot, A., Myers, T., Heitz, F., Sharma, S., Selçukbiricik, F., Aghajanian, C., Fernebro, J., Blank, S., Laudani, M. E., Thaker, P. H., Yunokawa, M., Willmott, L., Lisyanskaya, A., Hegg, R., He, Y., Landen, C. & Lin, Y. G. & 2 others, Alarcón, J. & Moore, K. N., Jun 2025, In: Gynecologic oncology. 197, p. 66-73 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Improving diverse patient enrollment in clinical trials, focusing on Hispanic and Asian populations: recommendations from an interdisciplinary expert panel

Pothuri, B., Thaker, P., Moore, A., Espinosa, R., Medina, K., Collyar, D., Lutz, K., Munteanu, M. C. & Slomovitz, B., Jun 2025, In: International Journal of Gynecological Cancer. 35, 6, 101875.

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma

Toboni, M. D., Dinkins, K., Wu, S., Mattox, T., Oberley, M. J., Thaker, P. H., Herzog, T. J., Powell, M. A. & Jones, N., Feb 2025, In: Gynecologic oncology. 193, p. 89-97 9 p.

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R. S., Shahin, M. S., Cantuaria, G. H., Girda, E., Lokich, E., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O’Cearbhaill, R. E. & Baghdadi, T. A. & 7 others, Hill, E. K., Thaker, P. H., John, V. S., Welch, S., Fader, A. N., Powell, M. A. & Aghajanian, C., May 2025, In: Nature medicine. 31, 5, p. 1539-1546 8 p.

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

Haight, P. J., Sanchez, M., Thomas, S. M., Smitherman, C., Cosgrove, C., Bae-Jump, V., Crafton, S., Hacker, K., Ko, E., Krivak, T., Lara, O., Moore, K., Mullen, M. M., Pothuri, B., Thaker, P. H., Washington, C., Arend, R., Corr, B., Duska, L. & Jackson, A. & 4 others, Konecny, G. E., Wright, J., Secord, A. & Backes, F., Mar 2025, In: Gynecologic oncology. 194, p. 98-104 7 p.

Research output: Contribution to journal › Article › peer-review

Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Duska, L. R., Petroni, G. R., Thaker, P. H., Crane, E. K., Holman, L. L., Armstrong, D. K., Romano, K. & Scalici, J., Feb 15 2025, In: Cancer. 131, 4, e35757.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

2024

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

Shi, V., Grover, S., Huang, Y., Thaker, P. H., Kuroki, L. M., Powell, M. A., Mutch, D. G., Contreras, J. A., Schwarz, J. K., Grigsby, P. W. & Markovina, S., Jun 1 2024, In: International Journal of Gynecological Cancer. 34, 6, p. 808-816 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

A toolkit for a modern gynecologic oncology tissue bank

Graham, O., Rodriguez, J., Abbott, R., Lomonosova, E., Fashemi, B., Drexler, R., Grither, W., Rodriguez, K., Compadre, A., Loeb, M., Sanders, B., Kuroki, L., Hagemann, A. R., McCourt, C., Thaker, P. H., Fuh, K., Powell, M. A., Hagemann, I. S., Mutch, D. G. & Khabele, D. & 1 others, Mullen, M. M., Oct 2024, In: Gynecologic oncology. 189, p. 1-8 8 p.

Research output: Contribution to journal › Article › peer-review

Borderline Tumors of the Ovary

Crane, E. K. & Thaker, P. H., Jan 1 2024, Textbook of Uncommon Cancer: Fifth Edition. wiley, p. 572-581 10 p.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study

Thaker, P. H., Boyle, T. A. C., Burns, S., Lim, J., Hartman, J., Kalilani, L. V., Schilder, J. M., Hurteau, J. A. & Golembesky, A. K., Dec 2 2024, In: International Journal of Gynecological Cancer. 34, 12, p. 1924-1931 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma

Rushton, T., Krause, H. B., Samec, T., Elliott, A., Karnezis, A. N., Toboni, M. D., Thaker, P. H., Braxton, D. R., Oberley, M., Gershenson, D. M. & Armstrong, D. K., Dec 2024, In: Gynecologic oncology. 191, p. 80-85 6 p.

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer

Grisham, R., Monk, B. J., Van Nieuwenhuysen, E., Moore, K. N., Fabbro, M., O'Malley, D. M., Oaknin, A., Thaker, P., Oza, A. M., Colombo, N., Gershenson, D., Aghajanian, C. A., Choi, C. H., Lee, Y. C., Mirza, M. R., Coleman, R. L., Cobb, L., Harter, P., Lustgarten, S. & Youssoufian, H. & 1 others, Banerjee, S., 2024, (Accepted/In press) In: International Journal of Gynecological Cancer.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

KRAS mutations in endometrial cancers: Possible prognostic and treatment implications

Kilowski, K. A., Dietrich, M. F., Xiu, J., Baca, Y., Hinton, A., Ahmad, S., Herzog, T. J., Thaker, P. & Holloway, R. W., Dec 2024, In: Gynecologic oncology. 191, p. 299-306 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets

McNally, L., Wu, S., Hodges, K., Oberley, M., Wallbillich, J. J., Jones, N. L., Herzog, T. J., Thaker, P. H., Secord, A. A. & Huang, M., May 2024, In: Gynecologic oncology. 184, p. 111-116 6 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

NCCN GUIDELINES^® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Liu, J., Berchuck, A., Backes, F. J., Cohen, J., Grisham, R., Leath, C. A., Martin, L., Matei, D., Miller, D. S., Robertson, S., Barroilhet, L., Uppal, S., Hendrickson, A. W., Gershenson, D. M., Gray, H. J., Hakam, A., Jain, A., Konecny, G. E., Moroney, J. & Ratner, E. & 20 others, Schorge, J., Thaker, P. H., Werner, T. L., Zsiros, E., Behbakht, K., Chen, L. M., DeRosa, M., Eisenhauer, E. L., Leiserowitz, G., Litkouhi, B., McHale, M., Percac-Lima, S., Rodabaugh, K., Vargas, R., Jones, F., Kovach, E., Hang, L., Ramakrishnan, S., Alvarez, R. D. & Armstrong, D. K., Oct 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 8, p. 512-519 8 p.

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Gien, L. T., Enserro, D. M., Block, M. S., Waggoner, S., Duska, L. R., Wahner-Hendrickson, A. E., Thaker, P. H., Backes, F., Kidd, M., Muller, C. Y., DiSilvestro, P. A., Covens, A., Gershenson, D. M., Moore, K. N., Aghajanian, C. & Coleman, R. L., Jul 2024, In: Gynecologic oncology. 186, p. 61-68 8 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Quality of life and survivorship in patients with low-grade ovarian cancer

Lemieux, M., Telles, R., Goodheart, M., Dahmoush, L., Hagemann, I., Penedo, F. J., Nandakumar, R., Cole, S. W., Sood, A. K., Lutgendorf, S. K. & Thaker, P. H., Nov 2024, In: Gynecologic oncology. 190, p. 96-103 8 p.

Research output: Contribution to journal › Article › peer-review

Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients

Telles, R., Zimmerman, M. B., Thaker, P. H., Slavich, G. M., Ramirez, E. S., Zia, S., Goodheart, M. J., Cole, S. W., Sood, A. K. & Lutgendorf, S. K., May 2024, In: Gynecologic oncology. 184, p. 139-145 7 p.

Research output: Contribution to journal › Article › peer-review

The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients

Lutgendorf, S. K., Telles, R. M., Whitney, B., Thaker, P. H., Slavich, G. M., Goodheart, M. J., Penedo, F. J., Noble, A. E., Cole, S. W., Sood, A. K. & Corn, B. W., Feb 2024, In: Brain, Behavior, and Immunity. 116, p. 362-369 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic

Telles, R., Zia, S., Greteman, B. B., Thaker, P. H., Penedo, F., Charlton, M. E., Goodheart, M. J., Armer, J. S., Noble, A., Sood, A. K. & Lutgendorf, S. K., 2024, In: Journal of Psychosocial Oncology. 42, 3, p. 299-314 16 p.

Research output: Contribution to journal › Article › peer-review

2023

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283

O'Cearbhaill, R. E., Miller, A., Soslow, R. A., Lankes, H. A., DeLair, D., Segura, S., Chavan, S., Zamarin, D., DeBernardo, R., Moore, K., Moroney, J., Shahin, M., Thaker, P. H., Wahner-Hendrickson, A. E. & Aghajanian, C., Sep 2023, In: Gynecologic oncology. 176, p. 16-24 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer

Holloway, R. W., Thaker, P., Mendivil, A. A., Ahmad, S., Al-Niaimi, A. N., Barter, J., Beck, T., Chambers, S. K., Coleman, R. L., Crafton, S. M., Crane, E., Ramez, E., Ghamande, S., Graybill, W., Herzog, T., Indermaur, M. D., John, V. S., Landrum, L., Lim, P. C. & Lucci, J. A. & 12 others, Mchale, M., Monk, B. J., Moore, K. N., Morris, R., O'malley, D. M., Reid, T. J., Richardson, D., Rose, P. G., Scalici, J. M., Silasi, D. A., Tewari, K. & Wang, E. W., Sep 1 2023, In: International Journal of Gynecological Cancer. 33, 9, p. 1458-1463 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment

Zhu, Q., Luo, H., Middleton, W. D., Itani, M., Hagemann, I. S., Hagemann, A. R., Hoegger, M. J., Thaker, P. H., Kuroki, L. M., MCourt, C. K., Mutch, D. G., Powell, M. A. & Siegel, C. L., Dec 2023, In: Ultrasound in Obstetrics and Gynecology. 62, 6, p. 891-903 13 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation

Toboni, M. D., Wu, S., Farrell, A., Xiu, J., Ribeiro, J. R., Oberley, M. J., Arend, R., Erickson, B. K., Herzog, T. J., Thaker, P. H. & Powell, M. A., Oct 2023, In: Gynecologic oncology. 177, p. 132-141 10 p.

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival

Kotnik, E. N., Mullen, M. M., Spies, N. C., Li, T., Inkman, M., Zhang, J., Martins-Rodrigues, F., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Hagemann, A. R., Powell, M. A., Mutch, D. G., Khabele, D., Longmore, G. D., Mardis, E. R., Maher, C. A., Miller, C. A. & Fuh, K. C., Dec 2023, In: Communications Biology. 6, 1, 688.

Research output: Contribution to journal › Article › peer-review

Open Access

17 Scopus citations

HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis

Bruce, S. F., Wu, S., Ribeiro, J. R., Farrell, A., Oberley, M. J., Winer, I., Erickson, B. K., Klc, T., Jones, N. L., Thaker, P. H. & Powell, M. A., May 2023, In: Gynecologic oncology. 172, p. 98-105 8 p.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized Trial

Yin, X., Davi, R., Lamont, E. B., Thaker, P. H., Bradley, W. H., Leath, C. A., Moore, K. M., Anwer, K., Musso, L. & Borys, N., 2023, In: JCO Clinical Cancer Informatics. 7, e2200103.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial

Landen, C. N., Molinero, L., Hamidi, H., Sehouli, J., Miller, A., Moore, K. N., Taskiran, C., Bookman, M., Lindemann, K., Anderson, C., Berger, R., Myers, T., Beiner, M., Reid, T., Van Nieuwenhuysen, E., Green, A., Okamoto, A., Aghajanian, C., Thaker, P. H. & Blank, S. V. & 4 others, Khor, V. K., Chang, C. W., Lin, Y. G. & Pignata, S., May 1 2023, In: Clinical Cancer Research. 29, 9, p. 1698-1707 10 p.

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy

Corvigno, S., Badal, S., Spradlin, M. L., Keating, M., Pereira, I., Stur, E., Bayraktar, E., Foster, K. I., Bateman, N. W., Barakat, W., Darcy, K. M., Conrads, T. P., Maxwell, G. L., Lorenzi, P. L., Lutgendorf, S. K., Wen, Y., Zhao, L., Thaker, P. H., Goodheart, M. J. & Liu, J. & 4 others, Fleming, N., Lee, S., Eberlin, L. S. & Sood, A. K., Dec 2023, In: npj Precision Oncology. 7, 1, 115.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Low grade endometrial stromal sarcoma in pregnancy: A case in support of safe abortion access

Furuya, R. L., Eisenberg, D. L., Gray, D. L., Mellnick, V. M. & Thaker, P. H., Dec 2023, In: Gynecologic Oncology Reports. 50, 101299.

Research output: Contribution to journal › Article › peer-review

Open Access

MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome

Kumar, A., Hollar, L., McGill, J. B., Thaker, P. H. & Salam, M., Jul 1 2023, In: AACE Clinical Case Reports. 9, 4, p. 112-115 4 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., Mathews, C., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O'Cearbhaill, R. E. & Al Baghdadi, T. & 7 others, Hill, E. K., Thaker, P. H., John, V. S., Welch, S., Fader, A. N., Powell, M. A. & Aghajanian, C., 2023, In: New England Journal of Medicine. 388, 23, p. 2159-2170 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

402 Scopus citations

Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., Mathews, C., Kavecansky, J., Leath, C. A., Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O'cearbhaill, R. E. & Al Baghdadi, T. & 7 others, Hill, E. K., Thaker, P. H., John, V. S., Welch, S., Fader, A. N., Powell, M. A. & Aghajanian, C., Jul 1 2023, In: Obstetrical and Gynecological Survey. 78, 7, p. 406-407 2 p.

Research output: Contribution to journal › Comment/debate

Open Access

1 Scopus citations

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

Ingham, M., Allred, J. B., Chen, L., Das, B., Kochupurakkal, B., Gano, K., George, S., Attia, S., Burgess, M. A., Seetharam, M., Boikos, S. A., Bui, N., Chen, J. L., Close, J. L., Cote, G. M., Thaker, P. H., Ivy, S. P., Bose, S., D'Andrea, A. & Marino-Enriquez, A. & 2 others, Shapiro, G. I. & Schwartz, G. K., Sep 1 2023, In: Journal of Clinical Oncology. 41, 25, p. 4154-4163 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

25 Scopus citations

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

Falcinelli, M., Al-Hity, G., Baron, S., Mampay, M., Allen, M. C., Samuels, M., Jones, W., Cilibrasi, C., Flaherty, R. L., Giamas, G., Thaker, P. H. & Flint, M. S., May 2023, In: Brain, Behavior, and Immunity. 110, p. 1-12 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Compadre, A. J., van Biljon, L. N., Valentine, M. C., Llop-Guevara, A., Graham, E., Fashemi, B., Herencia-Ropero, A., Kotnik, E. N., Cooper, I., Harrington, S. P., Kuroki, L. M., McCourt, C. K., Hagemann, A. R., Thaker, P. H., Mutch, D. G., Powell, M. A., Sun, L., Mosammaparast, N., Serra, V. & Zhao, P. & 3 others, Lomonosova, E., Khabele, D. & Mullen, M. M., Jul 1 2023, In: Clinical Cancer Research. 29, 13, p. 2466-2479 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

33 Scopus citations

Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer

Chan, J. K., Liu, J., Song, J., Xiang, C., Wu, E., Kalilani, L., Hurteau, J. A. & Thaker, P. H., Jul 1 2023, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 46, 7, p. 314-322 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Schab, A. M., Greenwade, M. M., Stock, E., Lomonosova, E., Cho, K., Grither, W. R., Noia, H., Wilke, D., Mullen, M. M., Hagemann, A. R., Hagemann, I. S., Thaker, P. H., Kuroki, L. M., McCourt, C. K., Khabele, D., Powell, M. A., Mutch, D. G., Zhao, P., Shriver, L. P. & Patti, G. J. & 2 others, Longmore, G. D. & Fuh, K. C., 2023, In: Molecular Cancer Research. 21, 11, p. 1234-1248 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

The Genomic Landscape of Vulvar Squamous Cell Carcinoma

Corey, L., Wallbillich, J. J., Wu, S., Farrell, A., Hodges, K., Xiu, J., Nabhan, C., Guastella, A., Kheil, M., Gogoi, R., Winer, I., Bandyopadhyay, S., Huang, M., Jones, N., Wilhite, A., Karnezis, A., Thaker, P., Herzog, T. J., Oberley, M. & Korn, W. M. & 3 others, Vezina, A., Morris, R. & Ali-Fehmi, R., Sep 1 2023, In: International Journal of Gynecological Pathology. 42, 5, p. 515-522 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes

Whelan, K., Dillon, M., Strickland, K. C., Pothuri, B., Bae-Jump, V., Borden, L. E., Thaker, P. H., Haight, P., Arend, R. C., Ko, E., Jackson, A. L., Corr, B. R., Ayoola-Adeola, M., Wright, J. D., Podwika, S., Smitherman, C., Thomas, S., Lightfoot, M., Newton, M. & Washington, C. & 7 others, Mullen, M., Cosgrove, C., Harsono, A. A. H., Powell, K., Herzog, T. J., Salani, R. & Alvarez Secord, A., Nov 2023, In: Gynecologic oncology. 178, p. 44-53 10 p.

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Two-year follow up on the impact of the COVID-19 pandemic on outcomes in gynecologic oncology patients

Turner, K., Bruce, S., Carbonell, K. V., Mullen, M. M., Hagemann, A. R., McCourt, C., Thaker, P., Khabele, D., Powell, M. A., Mutch, D. G. & Kuroki, L., Aug 2023, In: Gynecologic Oncology Reports. 48, p. S37

Research output: Contribution to journal › Conference article › peer-review

Open Access

2022

An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women with Newly Diagnosed Locally Advanced Cervical Cancer

Fracasso, P. M., Duska, L. R., Thaker, P. H., Gao, F., Zoberi, I., Dehdashti, F., Siegel, B. A., Uliel, L., Menias, C. O., Rehm, P. K., Goodner, S. A., Creekmore, A. N., Lothamer, H. L. & Rader, J. S., Jul 1 2022, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 45, 7, p. 286-293 8 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression

Lutgendorf, S. K., Thaker, P. H., Goodheart, M. J., Arevalo, J. M. G., Chowdhury, M. A., Noble, A. E., Dahmoush, L., Slavich, G. M., Penedo, F. J., Sood, A. K. & Cole, S. W., Dec 1 2022, In: Cancer. 128, 23, p. 4157-4165 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Zamorano, A. S., Mazul, A. L., Marx, C., Mullen, M. M., Greenwade, M., Stewart Massad, L., McCourt, C. K., Hagemann, A. R., Thaker, P. H., Fuh, K. C., Powell, M. A., Mutch, D. G., Khabele, D. & Kuroki, L. M., Dec 2022, In: Gynecologic Oncology Reports. 44, 101075.

Research output: Contribution to journal › Article › peer-review

Open Access

Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications

Dholakia, J., Cohen, A. C., Leath, C. A., Evans, E. T., Alvarez, R. D. & Thaker, P. H., Apr 2022, In: Current oncology reports. 24, 4, p. 389-397 9 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

9 Scopus citations

GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress

Mullen, M. M., Lomonosova, E., Toboni, M. D., Oplt, A., Cybulla, E., Blachut, B., Zhao, P., Noia, H., Wilke, D., Rankin, E. B., Kuroki, L. M., Hagemann, A. R., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Mutch, D. G., Powell, M. A., Mosammaparast, N., Vindigni, A. & Fuh, K., Feb 2022, In: Molecular Cancer Research. 20, 2, p. 265-279 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

34 Scopus citations

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Bruce, S. F., Cho, K., Noia, H., Lomonosova, E., Stock, E. C., Oplt, A., Blachut, B., Mullen, M. M., Kuroki, L. M., Hagemann, A. R., McCourt, C. K., Thaker, P. H., Khabele, D., Powell, M. A., Mutch, D. G., Shriver, L. P., Patti, G. J. & Fuh, K., Aug 2022, In: Molecular Cancer Therapeutics. 21, 8, p. 1348-1359 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Premal Thaker

Research output

Search results